XENT
Intersect ENT, Inc
XENT
XENT
Delisted
XENT was delisted on the 12th of May, 2022.
112 hedge funds and large institutions have $521M invested in Intersect ENT, Inc in 2019 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 20
25% less capital invested
Capital invested by funds: $690M → $521M (-$169M)
Holders
112
Holding in Top 10
3
Calls
$16.1M
Puts
$3.05M
Top Buyers
| 1 | +$23.6M | |
| 2 | +$13.3M | |
| 3 | +$9.31M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$6.8M |
| 5 |
PVI
Pura Vida Investments
New York
|
+$6.11M |
Top Sellers
| 1 | -$29.5M | |
| 2 | -$15.1M | |
| 3 | -$7.46M | |
| 4 |
HM
HealthCor Management
New York
|
-$3.98M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$3.96M |